FTC expands PBM investigation to include rebate negotiators
18 May 2023
Acquisition
The Federal Trade Commission, which this week sued to block Amgen’s $28 billion buyout of Horizon, is simultaneously expanding its probe into dubious practices from pharmacy benefit managers by going after two group purchasing organizations (GPOs) that negotiate drug rebates on behalf of PBMs.
The compulsory orders issued by the FTC will require Zinc Health Services, which is the GPO or rebate aggregator for CVS Caremark, and Ascent Health Services, which is the GPO for PBMs Express Scripts, Prime Therapeutics, Envolve Pharmacy Solutions, and Humana Pharmacy Solutions, to provide more information and records on their business practices.
Preview
Source: EndPoints
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 169,200+ biopharma pros reading Endpoints daily — and it's free.
SIGN UP
LOG IN
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.